Cargando…
Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan
INTRODUCTION: Although the proportion of patients with rheumatoid arthritis (RA) using biologic disease-modifying antirheumatic drugs (bDMARDs) has increased steadily, the relationship between patient background and preference for bDMARDs has not been fully investigated. METHODS: We conducted a web-...
Autores principales: | Kishimoto, Mitsumasa, Yamairi, Fumiko, Sato, Noriko, Kobayashi, Jun, Yamauchi, Saori, Iwasaki, Tomohisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178669/ https://www.ncbi.nlm.nih.gov/pubmed/34089509 http://dx.doi.org/10.1007/s40744-021-00325-9 |
Ejemplares similares
-
Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
por: Yamairi, Fumiko, et al.
Publicado: (2020) -
Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)
por: Yamaguchi, Ken-ichi, et al.
Publicado: (2012) -
Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making
por: Taylor, Peter C, et al.
Publicado: (2020) -
Preferred Mode of Therapy Among Patients in Rheumatoid Arthritis Saudi Database: A Cross-Sectional Study
por: Bukhari, Rahaf I, et al.
Publicado: (2023) -
Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'
por: Yoshida, Kazuki, et al.
Publicado: (2011)